Top compounds associated with response to TXNDC17


Feature Type Standardized
Nominal ANOVA
mRNA GDC-0941 CTRPv2 pan-cancer AAC -0.071 0.06
mRNA BRD-K99584050 CTRPv2 pan-cancer AAC 0.1 0.06
mRNA 17-AAG GDSC1000 pan-cancer AAC 0.062 0.06
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.063 0.06
mRNA alisertib CTRPv2 pan-cancer AAC -0.06 0.06
mRNA selumetinib:BRD-A02303741 (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.068 0.06
mRNA Carboplatin CTRPv2 pan-cancer AAC -0.069 0.06
mRNA PIK-93 CTRPv2 pan-cancer AAC -0.067 0.06
mRNA CH5424802 GDSC1000 pan-cancer AAC 0.064 0.06
mRNA rigosertib CTRPv2 pan-cancer AAC -0.062 0.06
Download CSV